Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profileg
Rigel Pharmaceuticals

@RigelPharma

Rigel is a biotech company dedicated to discovering, developing and providing novel therapies for hematologic disorders and cancer.

ID:125427343

linkhttp://www.rigel.com calendar_today22-03-2010 19:41:35

499 Tweets

2,2K Followers

38 Following

Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profile Photo

A special thank you to all the patients, clinicians, and clinical trial professionals who participate in our clinical trials and help us to advance care

A special thank you to all the patients, clinicians, and clinical trial professionals who participate in our clinical trials and help us to advance care #ClinicalTrailsDay #TrailblazersAmongUs
account_circle
Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profile Photo

$RIGL reports Q4 & FY 2023 financial results and provides business update. Link to press release: rigel.com/investors/news… Listen to webcast: rigel.com/investors/news…

$RIGL reports Q4 & FY 2023 financial results and provides business update. Link to press release: rigel.com/investors/news… Listen to webcast: rigel.com/investors/news…
account_circle
Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profile Photo

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update rigel.com/investors/news…

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update rigel.com/investors/news…
account_circle
Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profile Photo

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update rigel.com/investors/news…

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update rigel.com/investors/news…
account_circle
Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profile Photo

$RIGL today announced that it has entered into a definitive agreement to acquire the U.S. rights to GAVRETO® (pralsetinib) from Blueprint Medicines rigel.com/investors/news…

$RIGL today announced that it has entered into a definitive agreement to acquire the U.S. rights to GAVRETO® (pralsetinib) from @BlueprintMeds rigel.com/investors/news…
account_circle
Rigel Pharmaceuticals(@RigelPharma) 's Twitter Profile Photo

Did you know cancer is the 2nd leading cause of death worldwide? February 4th is World Cancer Day, an international day to raise awareness of cancer and to encourage its prevention, detection, and treatment. Learn more about at: worldcancerday.org

Did you know cancer is the 2nd leading cause of death worldwide? February 4th is World Cancer Day, an international day to raise awareness of cancer and to encourage its prevention, detection, and treatment. Learn more about #WorldCancerDay at: worldcancerday.org
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

MD Anderson and Rigel Pharmaceuticals announce a multi-year strategic collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia and other hematologic cancers. Learn more here: brnw.ch/21wF9gz

account_circle